Risk of progression following a negative biopsy in prostate cancer active surveillance

被引：0
|
作者：
Kerri Beckmann
Aida Santaolalla
Mikio Sugimoto
Peter Carroll
Jose Rubio
Arnauld Villers
Anders Bjartell
Todd Morgan
Prokar Dasgupta
Mieke Van Hemelrijck
Oussama Elhage
机构：
[1] University of South Australia,Cancer Epidemiology and Population Health Research Group
[2] Kings College London,Translational Oncology and Urology Research
[3] Kagawa University,Faculty of Medicine
[4] University of California San Francisco,Department of Urology, UCSF—Helen Diller Comprehensive Cancer Centre
[5] Instituto Valenciano de Oncologia,Department of Urology
[6] Lille University Hospital Center,Immunology and Microbial Sciences
[7] Skane University Hospital,undefined
[8] University of Michigan and Michigan Urological Surgery Improvement Collaborative,undefined
[9] Guy’s and St Thomas’ NHS Foundation Trust,undefined
[10] King’s College London,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2023年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：403 / 409
页数：6
相关论文
共 50 条
  • [31] CAN SURVEILLANCE BIOPSIES BE OMITTED AT FIRST MRI-INFORMED SURVEILLANCE BIOPSY IN LOW-RISK PROSTATE CANCER PATIENTS WITH NEGATIVE MRI ON ACTIVE SURVEILLANCE
    Chappidi, Meera R.
    Newcomb, Lisa F.
    Liu, Menghan
    Schenk, Jeannette M.
    Zheng, Yingye
    Zhu, Kehao
    de la Calle, Claire M.
    Lin, Daniel W.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E264 - E264
  • [32] PROGRESSION OF PATIENTS WITH LOCALIZED PROSTATE CANCER IN ACTIVE SURVEILLANCE
    Ozkan, T. A.
    Ustuner, M.
    Ozkan, L.
    Saribacak, A.
    Yilmaz, H.
    Muezzinoglu, B.
    Dillioglugil, O.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (06) : 562 - 562
  • [33] RADIOLOGICAL PROGRESSION IN MEN WITH PROSTATE CANCER ON ACTIVE SURVEILLANCE
    Ridout, Ashley J.
    Stevens, Daniel
    Allen, Clare
    Kirkham, Alex
    Emberton, Mark
    Moore, Caroline M.
    JOURNAL OF UROLOGY, 2013, 189 (04): : E552 - E552
  • [34] Does a Negative Prostate Biopsy Reduce the Risk of Prostate Cancer Reclassification in an Active Surveillance Protocol? An Updated Systematic Review and Meta-Analysis
    Bahri, Razman Arabzadeh
    Mohammadi, Abdolreza
    Yar, Ehsan Zemanati
    Rezayat, Mina
    Heshmat, Ramin
    Aghamir, Seyed Mohammad Kazem
    PROSTATE, 2025, 85 (05): : 482 - 491
  • [35] Transperineal prostate biopsy should be considered for patients undergoing active surveillance for low risk prostate cancer
    Moran, D.
    Mcloughlin, L.
    Inder, S.
    Lynch, T.
    BJU INTERNATIONAL, 2016, 118 : 27 - 27
  • [36] Active surveillance in low risk prostate cancer: Role of multiparametric MRI and cancer progression predictors
    Simforoosh, Nasser
    Dadpour, Mehdi
    Narouie, Behzad
    Madani, Mohammad Hamidi
    UROLOGIA JOURNAL, 2025,
  • [37] Predictors of Pathologic Progression on Biopsy Among Men on Active Surveillance for Localized Prostate Cancer: The Value of the Pattern of Surveillance Biopsies
    Cary, K. Clint
    Cowan, Janet E.
    Sanford, Melissa
    Shinohara, Katsuto
    Perez, Nannette
    Chan, June M.
    Meng, Maxwell V.
    Carroll, Peter R.
    EUROPEAN UROLOGY, 2014, 66 (02) : 337 - 342
  • [38] When is a Negative Prostate Biopsy Really Negative? Repeat Biopsies in Detection and Active Surveillance
    Loeb, Stacy
    JOURNAL OF UROLOGY, 2017, 197 (04): : 973 - 974
  • [39] Predicting Biopsy Outcomes During Active Surveillance for Prostate Cancer: External Validation of the Canary Prostate Active Surveillance Study Risk Calculators in Five Large Active Surveillance Cohorts
    Drost, Frank Jan H.
    Nieboer, Daan
    Morgan, Todd M.
    Carroll, Peter R.
    Roobol, Monique J.
    Trock, Bruce
    Ehdaie, Behfar
    Carroll, Peter
    Filson, Christopher
    Kim, Jeri
    Logothetis, Christopher
    Morgan, Todd
    Klotz, Laurence
    Pickles, Tom
    Hyndman, Eric
    Moore, Caroline M.
    Gnanapragasam, Vincent
    Van Hemelrijck, Mieke
    Dasgupta, Prokar
    Bangma, Chris
    Roobol, Monique
    Villers, Arnauld
    Rannikko, Antti
    Valdagni, Riccardo
    Perry, Antoinette
    Hugosson, Jonas
    Rubio-Briones, Jose
    Bjartell, Anders
    Hefermehl, Lukas
    Shiong, Lee Lui
    Frydenberg, Mark
    Kakehi, Yoshiyuki
    Ha Chung, Byung
    van der Kwast, Theo
    van der Linden, Wim
    Hulsen, Tim
    de Jonge, Cees
    Kattan, Mike
    Ji Xinge
    Muir, Kenneth
    Lophatananon, Artitaya
    Fahey, Michael
    Steyerberg, Ewout
    Zhang, Liying
    Beckmann, Kerri
    Denton, Brian
    Hayen, Andrew
    Boutros, Paul
    Guo, Wei
    Benfante, Nicole
    EUROPEAN UROLOGY, 2019, 76 (05) : 693 - 702
  • [40] PREDICTING PROGRESSION IN PATIENTS FOLLOWED WITH ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER
    Sternberg, Itay
    Yu, Changhong
    Paz, Gal Keren
    Kim, Philip
    Bernstein, Melanie
    Lakin, Paul
    Kattan, Michael
    Ehdaie, Behfar
    Laudone, Vincent
    Scardino, Peter
    Eastham, James
    Touijer, Karim
    JOURNAL OF UROLOGY, 2014, 191 (04): : E459 - E459
12345